Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berta Holding GmbH is a private German holding company that serves as the parent entity for Bionorica SE, one of the world's leading manufacturers of scientifically researched herbal medicines. The company specializes in phytoneering, a process that integrates traditional herbal knowledge with advanced pharmaceutical research and modern technology to develop high-efficacy phytopharmaceuticals. Its portfolio, managed through its subsidiaries, includes well-known brands such as Sinupret, Bronchipret, and Canephron, targeting respiratory, urological, and gynecological health. Berta Holding is controlled by the Popp family and is headquartered in Neumarkt in der Oberpfalz, Germany. The company maintains a significant international presence, particularly in Europe and Central Asia, and continues to invest heavily in clinical validation for its plant-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berta Holding.